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ABSTRACT
Besides TopBP1, ETAA1 has been identified more recently as an activator of the ATR-ATRIP complex
in human cells. We have examined the role of ETAA1 in the Xenopus egg-extract system, which has
been instrumental in the study of ATR-ATRIP. Depletion of ETAA1 from egg extracts did not
noticeably reduce the activation of ATR-ATRIP in response to replication stress, as monitored by
the ATR-dependent phosphorylation of Chk1 and RPA. Moreover, lack of ETAA1 did not appear to
affect DNA replication during an unperturbed S-phase. Significantly, we find that TopBP1 is
considerably more abundant than ETAA1 in egg extracts. We proceeded to show that ETAA1
could support the activation of ATR-ATRIP in response to replication stress if we increased its
concentration in egg extracts by adding extra full-length recombinant ETAA1. Thus, TopBP1 appears
to be the predominant activator of ATR-ATRIP in response to replication stress in this system. We
have also explored the biochemical mechanism by which ETAA1 activates ATR-ATRIP. We have
developed an in vitro system in which full-length recombinant ETAA1 supports activation of ATR-
ATRIP in the presence of defined components. We find that binding of ETAA1 to RPA associated with
single-stranded DNA (ssDNA) greatly stimulates its ability to activate ATR-ATRIP. Thus, RPA-coated
ssDNA serves as a direct positive effector in the ETAA1-mediated activation of ATR-ATRIP.
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Introduction
Eukaryotic cells must carefully assess the fidelity of the
various processes that eventually lead to successful
cellular duplication. For example, cells must possess
the means to allow faithful replication of the genome
and accurate transmission of the duplicated copies to
their progeny. Toward this end, cells employ various
types of checkpoint-regulatory pathways [1,2]. For
example, the kinase ATR and its regulatory partner
ATRIP function at the apex of pathways that monitor
the fidelity of DNA synthesis during S-phase. ATR-
ATRIP also regulates responses to damaged DNA as
well as other processes.
The functioning of ATR-ATRIP in checkpoint
pathways is subject to stringent regulation. For
example, ATR-ATRIP first localizes to potentially
problematic regions in the genome by docking with
RPA-coated single-stranded DNA (ssDNA), which
accumulates at stalled replication forks and other
structures [3,4]. However, ATR-ATRIP exhibits
minimal kinase activity in the presence of only RPA-
ssDNA [5–7]. Hence, other proteins must come into
play to activate ATR-ATRIP so that it can phosphor-
ylate downstream target proteins. In a well charac-
terized pathway, binding of TopBP1 to ATR-ATRIP
shifts the kinase into its activated conformation [8–
10]. TopBP1 achieves this effect by utilizing an ATR-
activating domain (AAD), which interacts with both
the ATR and ATRIP subunits [8,11].
Other significant aspects of this process are that
the association of TopBP1 with checkpoint-inducing
structures on chromatin and its subsequent interac-
tion with ATR-ATRIP are also under strict control.
For example, TopBP1 docks with the Rad9-Hus1-
Rad1 (9-1-1) checkpoint clamp after deposition of
this complex onto recessed DNA ends at stalled
replication forks by the Rad17-RFC checkpoint
clamp loader [12,13]. In addition, the Mre11-Rad50-
Nbs1 (MRN) complex regulates the activation of
ATR-ATRIP in response to replication stress, at
least in part by facilitating the recruitment of
TopBP1 to chromatin [14,15].
The role of TopBP1 in the activation of ATR-
ATRIP is also conserved in budding yeast. In this
system, Dpb11, the yeast homologue of TopBP1,
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directly activates Mec1-Ddc2, the yeast version of
ATR-ATRIP [16]. Significantly, however, additional
proteins can also serve as activators of Mec1-Ddc2 in
yeast. For example, the C-terminal tail of Ddc1 (the
yeast homologue of the Rad9 subunit of the vertebrate
9-1-1 complex) also possesses an AAD [17].
Moreover, the Dna2 protein contains a functional
AAD [18]. The diversity of AAD-containing proteins
in yeast enables regulation of Mec1-Ddc2 in response
to different needs throughout the cell cycle. Such
observations raised the question of whether additional
activators of ATR might exist in higher eukaryotes.
More recently, several groups identified a novel
activator of ATR-ATRIP in human cells called
ETAA1 [19–22]. It has been shown that ETAA1
possesses a functional AAD and interacts with
RPA through multiple binding motifs. Moreover,
ETAA1 is important for the maintenance of geno-
mic stability following various perturbations.
However, the exact relationship between ETAA1
and TopBP1 as well as the regulation of ETAA1
are both topics that need further study.
In this report, we have characterized a homologue
of ETAA1 in the Xenopus egg-extract system in order
to assess its role relative to TopBP1. We have also
developed an in vitro systemwith defined components
to reveal that RPA-coated ssDNA plays an important
role in the activation of ATR-ATRIP by ETAA1.
Materials and methods
Xenopus egg extracts
Xenopus interphase egg extracts were prepared as
described previously [23]. Cycloheximide (50 µg/
ml) was added to prevent extracts from entering
mitosis. For induction of stalled DNA replication
forks, demembranated sperm nuclei (3000/μl)
were incubated in extracts with 150 μM (50 μg/
ml) aphidicolin, unless indicated otherwise.
Chromosomal DNA replication assays were car-
ried out as described previously [23].
Isolation of nuclear and chromatin fractions
For isolation of nuclear fractions, egg extracts were
overlaid on a 1 M sucrose cushion (1M sucrose,
80 mM KCl, 2.5 mM K-gluconate, 10 mM Mg-
gluconate, and 20 mM HEPES-KOH, pH 7.5) and
centrifuged at 6,100 g for 5 min. Nuclear pellets
were washed once with 1M sucrose cushion.
Nuclear fractions were dissolved in SDS sample
buffer for gel loading.
For isolation of chromatin fractions, extracts
were mixed with egg lysis buffer (ELB; 10 mM
HEPES-KOH, pH 7.7, 250 mM sucrose, 50 mM
KCl, and 2.5 mM MgCl2) containing 0.2% Triton
X-100. The suspended extracts were layered onto
a 0.5 M sucrose cushion (ELB containing an addi-
tional 0.25 M sucrose and 0.2% Triton X-100) and
centrifuged at 11,700 g for 1 min. The pellet was
washed once with ELB containing 0.2% Triton
X-100. Chromatin fractions were dissolved in
SDS gel sample buffer.
Antibodies
The coding sequence for Xenopus ETAA1 (GenBank:
BC076732.1) was amplified from XGC ETAA1
cDNA (Dharmacon) with Q5 High-Fidelity DNA
Polymerase (New England Biolabs). To produce
a His10-tagged polypeptide containing residues
374–820 of Xenopus ETAA1, we cloned the appro-
priate DNA sequence into pH10UE [24] and
expressed the protein in Escherichia coli Rosetta
(DE3)pLysS cells. Anti-Xenopus ETAA1 antibodies
were produced in rabbits in a commercial facility
(Pocono Rabbit Farm and Laboratory) and affinity
purified with the antigen. Affinity-purified rabbit
polyclonal antibodies against Xenopus Chk1, ATR,
ATRIP, Orc2, RPA70, BLM, Mre11, Cdc45, and
TopBP1 were described previously [8,15,25–28]. We
purchased the following anti-phosphopeptide antibo-
dies from commercial sources: pSer-345 of human
Chk1, equivalent to pSer-344 of Xenopus Chk1 (Cell
Signaling Technology); and pSer-33 of human
RPA32, equivalent to pThr-36 of Xenopus RPA32
(Bethyl Laboratories). An anti-human Mcm2 mouse
monoclonal antibody (BM28) that cross-reacts with
Xenopus Mcm2 was obtained from BD Transduction
Laboratories. Antiserum against Xenopus RPA32 was
kindly provided by Dr. Vincenzo Costanzo (FIRC
Institute of Molecular Oncology).
Immunodepletion
For immunodepletion of ETAA1, egg extracts
(100 μl) were incubated at 4°C for 1 h with 7.5
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μg anti-ETAA1 antibodies bound to protein
A Dynabeads (Invitrogen) for two rounds of treat-
ment. Mock depletions were performed with rab-
bit IgG fraction (Invitrogen). Immunodepletion of
TopBP1 was described previously [8].
Preparation of recombinant proteins
A recombinant baculovirus encoding Xenopus
ETAA1 with a His6 tag at the N-terminal end and
tandem 3X-FLAG and 2X-Strep tags at the
C-terminal end (HFS-ETAA1) was generated with
the Bac-to-Bac system (Invitrogen). To prepare
recombinant HFS-ETAA1 protein, Sf9 insect cells
were infected with the baculovirus and incubated
for 2 days. Cell pellets were lysed in 2 ml lysis buffer
(10 mM HEPES-KOH, pH 7.5, 300 mM NaCl, 1%
NP-40, and 1.5 mM EGTA) containing 1 mM
PMSF. Cell lysates were clarified by centrifugation
at 16,000 g for 10 min. The supernatants were then
diluted to 150 mMNaCl. For purification by means
of the His6 tag, diluted supernatants were incubated
with nickel agarose beads for 1 h. After the beads
were washed, proteins were eluted with 100 μl His6
elution buffer (10 mM HEPES-KOH, pH 7.5,
150 mM NaCl, and 300 mM imidazole). For pur-
ification with the FLAG tag, diluted supernatants
were incubated with anti-FLAG M2 agarose beads
(Sigma) for 2 h. After washing of the beads, proteins
were eluted with 100 μl FLAG elution buffer
(10 mM HEPES-KOH, pH 7.5, 150 mM NaCl,
0.5 mg/ml 3X-FLAG peptide, 1 mM DTT, 1 mM
EDTA, and 10 μg/ml each of pepstatin, chymosta-
tin, and leupeptin). Aliquots of purified proteins
were frozen in liquid nitrogen and stored at − 80°
C. Procedures for isolation of human p27 and
human RPA were previously described [25,29].
The FLAG-tagged polypeptide containing BRCT
domains I-III of Xenopus TopBP1 was prepared
by published methods [8].
Isolation of ATR-ATRIP complexes from egg
extracts
Preparation of ATR-ATRIP complexes in egg extracts
with recombinant, FLAG-tagged full-length ATRIP
or ΔN222-ATRIP and endogenous ATR was carried
out as described previously [8].
Kinase assays
Kinase assays with ATR-ATRIP complexes were per-
formed in the presence of γ-[32P]ATP under the same
conditions as before [8]. HFS-ETAA1 and RPA were
added at final concentrations of 141 nM and 991 nM,
respectively, as indicated. In some cases, a single-
stranded DNA containing 138 nucleotides (5'-GAT
ATC AGG GCC CTG GAA CAG CAC CTC CAG
GGC GCC TTT TTC GAA CTG AGG GTG GCT
CCA GGC GCT GCC TCC GGA TCC GCC TCC
GGA GCC TCC GCC TTT CTC GAA CTG AGG
GTGGCTCCAGCTAGCCATGGTGGGTCT-3')
was included at a final concentration of 188 nM.
Quantitation
For quantitation, immunoblots were analyzed with
the Odyssey Imaging System (LI-COR Biosciences).
Scanned images were quantified with Fiji (ImageJ).
Kinase assay gels were scanned with a Typhoon
FLA 9500 phosphorimager and the images were
quantified with Fiji (ImageJ).
Results
Characterization of a Xenopus homologue of
ETAA1
In order to study ETAA1 in the Xenopus egg-
extract system, we produced rabbit polyclonal
antibodies against residues 374–820 of a Xenopus
homologue of ETAA1. We found that these anti-
bodies recognize a polypeptide of approximately
134 kD in Xenopus egg extracts (Figure 1(a)). In
parallel, we also prepared a recombinant form of
Xenopus ETAA1 with His6, FLAG, and Twin-
Strep tags in baculovirus-infected insect cells. We
designated this construct as the HFS-ETAA1 pro-
tein. The electrophoretic mobility of the HFS-
ETAA1 protein was consistent with the addition
of the tags onto the ETAA1 protein (Figure 1(a)).
By quantitative immunoblotting, we noted that
ETAA1 is present at a concentration of approxi-
mately 7.5 nM in egg extracts (Figure 1(b)). This
value agrees quite well with the concentration of
8 nM that was obtained in a global proteomic ana-
lysis of egg extracts [30]. By comparison, it has been
estimated that TopBP1 is present at a concentration
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of 30 nM in egg extracts [31], which likewise is
consistent with the value of 37 nM from the pro-
teomic analysis. Hence, ETAA1 appears to be pre-
sent at approximately a four- to five-fold lower
concentration than TopBP1 in egg extracts.
Xenopus ETAA1 associates with chromatin in a
checkpoint-dependent manner
Many regulators of ATR accumulate on chromatin
in egg extracts upon replication stress [25,32–34]. By
mass spectrometry analysis, Haahr et al. [21]
observed enrichment of ETAA1 on chromatin
following treatment with the DNA polymerase inhi-
bitor aphidicolin (APH). We utilized our anti-
Xenopus ETAA1 antibodies to characterize this pro-
cess in further detail. For this purpose, we incubated
demembranated Xenopus sperm chromatin in egg
extracts to form reconstituted nuclei. To elicit the
formation of stalled DNA replication forks, we uti-
lized APH [35]. We incubated egg extracts in the
absence and presence of APH, isolated reconstituted
nuclei at different times, prepared chromatin frac-
tions, and immunoblotted for ETAA1 (Figure 1(c)).
We found that only small amounts of ETAA1 bound
to chromatin in the absence of APH. By contrast,
Figure 1. Characterization of ETAA1 in Xenopus egg extracts. (a) Interphase egg extracts were immunoblotted with antibodies
against Xenopus ETAA1 (lane 1). Recombinant, baculovirus-expressed HFS-ETAA1 protein (lane 2) was electrophoresed on the same
gel and immunoblotted with anti-ETAA1 antibodies. (b) Concentration of ETAA1 in egg extracts. The indicated amounts (ng) of
antigen used for the production of anti-ETAA1 antibodies (His10-tagged version of residues 374–820) were mixed with egg extracts.
Mixtures were subjected to gel electrophoresis and immunoblotted with anti-ETAA1 antibodies. Amounts of egg extract correspond
to: 1 μl (lanes 1–4); 0.5 μl (lane 5); and 0.2 μl (lane 6). (c) Interphase egg extracts were incubated without (lane 1) or with sperm
chromatin (lanes 2–9) in the absence (lanes 1–5) or presence of APH (lanes 6–9). Chromatin fractions were isolated from the extracts
at the indicated times and immunoblotted for ETAA1, RPA70, and Orc2 (loading control). Lane 10 depicts the initial egg extract.
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there was a large increase in the amount of ETAA1
on chromatin from APH-treated extracts (Figure 1
(c), compare lanes 2–5 and 6–9). This increase mir-
rored a similar elevation in the binding of RPA,
which we followed by immunoblotting of RPA70,
the largest subunit of the RPA complex. Moreover,
we noted that a large proportion of the chromatin-
bound ETAA1 showed a substantially reduced
electrophoretic mobility indicative of a post-
translational modification(s). We also observed
a lower-molecular weight band of ETAA1, which
may represent a breakdown product. Under these
conditions, RPA70 and Orc2 exhibited no signs of
degradation. Overall, these results indicated that
a highly modified form of ETAA1 accumulates on
chromatin undergoing replication stress.
Depletion of Xenopus ETAA1 does not
appreciably affect the checkpoint-dependent
phosphorylation of Chk1 and RPA
To evaluate whether ETAA1 has a role in checkpoint
regulation in egg extracts, we set out to remove this
protein from these extracts by immunodepletion.
We found that our anti-ETAA1 antibodies were
very effective for this purpose (Figure 2(a)). After
two rounds of treatment with protein A beads that
had been coated with anti-ETAA1 antibodies, we
could not detect any ETAA1 in egg extracts by
immunoblotting. Depletion of ETAA1 did not
noticeably affect the levels of TopBP1. Next, we
incubated ETAA1-depleted extracts as well as mock-
depleted extracts in the absence and presence of
APH. Subsequently, we isolated nuclear fractions
from the extracts and performed immunoblotting
to detect phosphorylation of Chk1 on Ser-344, an
indicator for activation of ATR in egg extracts
[26,36]. As expected, Chk1 underwent robust phos-
phorylation in the presence of APH (Figure 2(b)).
However, we could not observe any apparent reduc-
tion in the APH-dependent phosphorylation of
Chk1 in the absence of ETAA1.
We also probed for phosphorylation of RPA32,
the middle subunit of the RPA complex, on Thr-
36, the equivalent of Ser-33 in human RPA32 [14]
and likewise detected no difference in the absence
versus presence of ETAA1. As expected, ETAA1 in
nuclear fractions from mock-depleted extracts had
become highly modified in response to APH, and
there was no ETAA1 detectable in nuclear frac-
tions from ETAA1-depleted extracts (Figure 2(c)).
For these experiments, we utilized a relatively high
concentration of APH (150 μM), which results in
stalled replication forks with relatively short nas-
cent DNA [37,38]. However, we obtained the same
results with a lower dose of APH (15 μM), which
results in longer stretches of nascent DNA (Figure
2(d)). Similarly, we observed that phosphorylation
of Chk1 occurred normally in ETAA1-depleted
extracts that we had treated with the restriction
endonuclease PflMI to induce double-stranded
DNA breaks (not shown). Taken together, these
results indicate that ETAA1 plays little, if any role,
in the activation of ATR in response to APH-
triggered stalled replication forks in the Xenopus
egg-extract system. These observations are consis-
tent with the fact that depletion of TopBP1, the
first identified activator of ATR, eliminates phos-
phorylation of Chk1 under essentially the same
conditions that we have used in this study [8].
Role of ETAA1 in DNA replication
In the human system, it has been reported that there
is increased origin firing in ETAA1-deficient cells
[19,21]. A key step in origin firing involves the load-
ing of Cdc45 onto chromatin, which results in acti-
vation of the replicative helicase [39–41]. Inhibition
of ATR in APH-treated egg extracts results in dysre-
gulated origin firing, which is reflected in elevated
loading of Cdc45 onto chromatin [37,38,42,43].
Accordingly, we removed ETAA1 from egg extracts,
incubated the extracts in the presence of APH, and
finally isolated chromatin to examine the loading of
Cdc45 (Figure 3(a)). By immunoblotting, we
observed similar amounts of Cdc45 on chromatin
in APH-treated extracts in the absence and presence
of ETAA1. Under such conditions, addition of caf-
feine (an inhibitor of ATR and ATM) to APH-
treated extracts results in a dramatic increase in the
recruitment of Cdc45 to chromatin [37,38,42,43].
Therefore, it appears that ETAA1 does not play
a determinative role in the suppression of origin
firing in response to APH.
In order to evaluate whether ETAA1 has any role
in DNA replication during an unperturbed cell cycle,
we examined incorporation of 32P-lableled dAMP
(from a radiolabeled deoxynucleoside triphosphate
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Figure 2. Effect of depletion of ETAA1 on APH-induced phosphorylation of Chk1 and RPA in egg extracts. (a) Egg extracts (lane 1) were mock
depleted with control antibodies (lane 2) or immunodepleted with anti-Xenopus ETAA1 antibodies (lane 3) and immunoblotted for ETAA1 and
TopBP1, as indicated. (b) Untreated (lanes 1–2), mock-depleted (lanes 3–4), and ETAA1-depleted egg extracts (lanes 5–6) were incubated for
90 min in the absence (lanes 1, 3, and 5) or presence (lanes 2, 4, and 6) of 150 μMAPH. Nuclear fractions from the extracts were prepared and
immunoblotted with anti-phospho-Chk1 (p-Chk1), anti-Chk1, anti-phospho-RPA32 (p-RPA32), and anti-RPA32 antibodies. Lane 7 depicts the
initial egg extract. (c) Mock-depleted (lanes 1–4) and ETAA1-depleted egg extracts (lanes 5–8) were incubated for 90 min or 180 min in the
absence (lanes 1, 2, 5, and 6) or presence (lanes 3, 4, 7, and 8) of 150 μMAPH. Nuclear fractions were prepared and immunoblotted with anti-
ETAA1 antibodies. Note that the space between lanes 5 and 6 is a blank lane. Lane 9 depicts the initial egg extract. (d) Untreated (lanes 1–3),
mock-depleted (lanes 4–6), and ETAA1-depleted egg extracts (lanes 7–9)were incubated for 90min in the absence of APH (lanes 1, 4, and 7) or
the presence of either 15 μM (lanes 2, 5, and 8) or 150 μM APH (lanes 3, 6, and 9). Nuclear fractions from the extracts were prepared and
immunoblotted with the indicated antibodies. Lane 10 depicts the initial egg extract.
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Figure 3. Role of ETAA1 in DNA replication and related processes. (a) Mock-depleted (lanes 1–3) and ETAA1-depleted egg extracts
(lanes 4–6) containing APH were incubated in the absence of sperm chromatin for 45 min (lanes 1 and 4) or the presence of sperm
chromatin (lanes 2–3 and 5–6) for the indicated times. Incubations were processed for the preparation of chromatin fractions and
the resulting samples were immunoblotted for Mcm2, Cdc45, and Orc2. Lane 7 depicts an aliquot of the initial egg extract. (b) Mock-
depleted and ETAA1-depleted egg extracts were assayed for chromosomal DNA replication with 32P-labeled dATP at the indicated
times as indicated. An agarose gel containing radiolabeled replication products (top) and corresponding quantitation (bottom) are
depicted. Values are normalized to the amount of DNA replication at 90 min in mock-depleted extracts. Representative of three
experiments. (c) Mock-depleted (lanes 1–5) and ETAA1-depleted egg extracts (lanes 6–10) were incubated in the absence (lanes 1
and 6) or presence of sperm chromatin (lanes 2–5 and 7–10). In addition, extracts either lacked (lanes 2, 4, 7, and 9) or contained
APH (lanes 1, 3, 5, 6, 8, and 10). After incubation for the indicated times, extracts were processed for the preparation of chromatin
fractions and the resulting samples were immunoblotted for BLM, TopBP1, Mre11, RPA70, and Orc2. Lane 11 depicts an aliquot of
the initial egg extract. Note that the space between lanes 7 and 8 is a blank lane.
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precursor) into chromosomal DNA as a function of
time.We observed very similar time-courses for DNA
replication in the presence and absence of ETAA1
(Figure 3(b)). Therefore, absence of ETAA1 does not
appear to affect the overall progression of DNA repli-
cation in an obvious manner.
Bass et al. [19] also observed that ETAA1 associates
with other DNA damage-response proteins, including
the BLM/Top3α/RMI1/RMI2 complex, that are
involved in the repair of stalled replication forks. We
examined whether depletion of ETAA1 might affect
the recruitment of BLM to chromatin. In parallel, we
also examined TopBP1 and Mre11, a component of
the Mre11-Rad50-Nbs1 (MRN) complex, and RPA.
We observed that lack of ETAA1 did not typically
impair the binding of BLM, TopBP1, Mre11, or RPA
to chromatin (Figure 3(c)). Taken together, these
results suggest that absence of ETAA1 does not dra-
matically affect replication and some replication-
related processes in egg extracts.
ETAA1 can substitute for TopBP1 when present
at a sufficiently high concentration
As described above, ETAA1 is present at signifi-
cantly lower concentrations (four- to five-fold)
than TopBP1 in egg extracts. Accordingly, we
wished to examine whether ETAA1 could substi-
tute for TopBP1 to support the APH-triggered
activation of ATR if present at a higher concentra-
tion. To address this issue clearly, we decided to
remove TopBP1 from egg extracts by immunode-
pletion and then add extra recombinant ETAA1 to
the extracts (Figure 4). A consideration for this
approach is that TopBP1 is necessary for chromo-
somal DNA replication [31,44]. Thus, addition of
APH to TopBP1-depleted extracts does not result
in the formation of stalled replication forks, which
are a prerequisite for activation of ATR-ATRIP
and the ensuing phosphorylation of Chk1.
Certain truncation mutants of TopBP1 are able to
support initiation of replication but cannot promote
activation of ATR [9,10,23]. For example, a truncated
form of TopBP1 containing BRCT domains I-III can
support normal levels of DNA replication in egg
extracts [23]. This polypeptide lacks the AAD, which
resides between BRCT domains VI and VII, and thus
cannot activate ATR. Accordingly, we depleted egg
extracts of their endogenous TopBP1 and then added
a recombinant TopBP1 BRCT I-III fragment back to
the extracts in order to support initiation of DNA
replication (Figure 4(a and b)). Parenthetically, we
consistently noticed that there was a partial reduction
in the amount of ETAA1 in TopBP1-depleted
extracts. We could detect some ETAA1 in anti-
TopBP1 immunoprecipitates. However, this binding
was sensitive to washing with 0.1% NP-40 (not
shown). Therefore, TopBP1 and ETAA1 may form
a weak complex in egg extracts.
Next, we proceeded to add recombinant ETAA1 to
the extracts at a concentration of approximately
50 nM, which is slightly higher than the concentration
of endogenous TopBP1 (30–37 nM). Finally, we incu-
bated the extracts in the absence and presence of APH
and thenmonitored the phosphorylation of Chk1 and
RPA. As expected, there was no phosphorylation of
Chk1 or RPA in APH-treated, TopBP1-depleted
extracts (Figure 4(b)). Addition of the TopBP1
BRCT I-III fragment did not restore phosphorylation
of these proteins. On the other hand, further addition
of recombinant HFS-ETAA1 to such extracts resulted
in efficient phosphorylation of Chk1 and RPA in the
presence of APH (Figure 4(b)). In control experi-
ments, we showed that added recombinant ETAA1
could not induce phosphorylation of Chk1 in mock-
depleted extracts (Figure 4(c)). Taken together, these
results suggest that ETAA1 can substitute for TopBP1
in egg extracts if present at a sufficiently high
concentration.
RPA-ssDNA promotes the ETAA1-dependent
activation of ATR-ATRIP in a defined biochemical
system
An important question involves the issue of what
cellular factor(s) might regulate the ability of ETAA1
to activate ATR. For example, interaction of TopBP1
with the 9-1-1 and MRN complexes regulates its
ability to trigger the activation of ATR [12–15]. To
address this question, we attempted to set up
a defined in vitro system in which the activation of
ATR-ATRIP would be dependent upon addition of
recombinant full-length ETAA1 protein (Figure 5).
For this purpose, we utilized the recombinant HFS-
ETAA1 protein. As the source of ATR-ATRIP, we
prepared a complex of ATR and FLAG-tagged
ATRIP by using Xenopus egg extracts, as described
previously (Figure 5(a)) [8]. For most experiments,
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we utilized full-length ATRIP. Initially, we mixed
HFS-ETAA1 and ATR-ATRIP in the presence of
model ATR substrates, e.g., PHAS-I and a GST-
tagged fusion protein containing residues 62–122
of Xenopus Mcm2 [8]. However, we could not
observe significant phosphorylation of these sub-
strates above background levels with full-length
HFS-ETAA1 (not shown).
Previous studies have indicated that human
ETAA1 exhibits highly specific binding to RPA [19–
22]. Hence, we asked whether RPA could promote the
ability of ETAA1 to activate ATR-ATRIP. For this
purpose, we utilized recombinant human RPA that
had been purified from bacteria (Figure 5(b)) [29].
Since RPA functions through binding to ssDNA, we
also included an ssDNA template in some incuba-
tions. For these experiments, we utilized an oligonu-
cleotide comprised of a 138-mer of ssDNA. A DNA
molecule of this lengthwould be able to accommodate
multiple RPA molecules, approximately four [45,46].
We proceeded to incubateHFS-ETAA1 andATR-
ATRIP in the presence of RPA or ssDNA or both
(Figure 5(c)). Although we could observe some
phosphorylation of the middle subunit of RPA
(RPA32) in the absence of DNA, the addition of
ssDNA greatly stimulated the phosphorylation of
RPA32 (Figure 5(c), compare lanes 8 and 10). In
particular, inclusion of ssDNA resulted in a
4.9 ± 0.6-fold increase (mean ± SEM, n = 4 experi-
ments) in the phosphorylation of RPA32. This reac-
tion appears to be specific for RPA32 because we did
not observe any phosphorylation of RPA70 or
RPA14 in these experiments. As a control, we per-
formed the reactions in the presence of ssDNAbut in
the absence of RPA in order to confirm that the
phosphorylated band corresponds to RPA32
(Figure 5(c), lane 9). By using anti-phosphopeptide
antibodies, we established that at least one phosphor-
ylation site in RPA32 corresponds to Ser-33. This
residue is a well-documented target of ATR [47,48].
a
Ex
tra
ct
M
oc
k
To
pB
P1
 
TopBP1 
ETAA1 
1 2 3
b
p-RPA32
p-Chk1
RPA32
Mock TopBP1 
- + + + +
+ +
+ E
xt
ra
ct APH
BRCT I-III
HFS-ETAA1
Chk1
Nuclear Fractions
1 2 3 4 5 6
c
p-RPA32
p-Chk1
Mock
- + - +
+ +
APH
HFS-ETAA1
Chk1
Nuclear Fractions
1 2 3 4
RPA32
Figure 4. ETAA1 can substitute for TopBP1 when present at a sufficiently high concentration. (a) Egg extracts (lane 1) were mock-
depleted with control antibodies (lane 2) or immunodepleted with anti-TopBP1 antibodies (lane 3) and immunoblotted with anti-
TopBP1 (top) or anti-ETAA1 antibodies (bottom). (b) Mock-depleted (lanes 1 and 2) and TopBP1-depleted extracts (lanes 3–5) were
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or presence of APH (lanes 2 and 4). Some extracts were supplemented with recombinant HFS-ETAA1 protein (lanes 3 and 4). Nuclear
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There was no phosphorylation of RPA32 in the
presence of only ATR-ATRIP and RPA-ssDNA
(Figure 5(c), lane 11). Furthermore, no phosphor-
ylation of RPA32 occurred in the presence of
control preparations that lacked ATR-ATRIP
(Figure 5(c), lanes 1–5). We also noted that in
the complete reactions the ETAA1 protein itself
underwent phosphorylation (Figure 5(c), lane 10).
As was the case for phosphorylation of RPA, phos-
phorylation of ETAA1 was highest in the presence
of both RPA and ssDNA. Therefore, ETAA1 itself
also appears to be a substrate of ATR-ATRIP.
In order to establish that the phosphorylation of
RPA is indeed due to ATR-ATRIP, we made use of
a specific ATR kinase inhibitor called ETP-46464
(ATRi) [49]. We observed that addition of ATRi
completely inhibited the phosphorylation of RPA in
the cell-free reaction (Figure 5(c), lane 12). This inhi-
bitor also blocked the phosphorylation of ETAA1.
ETAA1 carries out the activation of ATR by uti-
lizing an ATR-activating domain (AAD), which was
initially found in TopBP1 [8]. This domain is well
conserved in ETAA1 [19,21,22]. All known AADs
contain a critical tryptophan residue. Mutation of
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Figure 5. Full-length ETAA1 activates ATR-ATRIP in a defined biochemical system. (a) Isolation of ATR-ATRIP complexes. Control
buffer (lane 1) and full-length ATRIP-FLAG (lane 2) were added to egg extracts containing anti-FLAG M2 antibody beads. After
incubation, the beads were reisolated, washed, and incubated with 3X-FLAG peptide. The eluates were immunoblotted with anti-
ATR (top) and anti-FLAG antibodies (bottom). (b) Purification of RPA. Recombinant human RPA was purified as described in Materials
and Methods and stained with Coomassie blue. (c) Control eluates (lanes 1–5) and eluates containing ATR-ATRIP complex (lanes
6–12) from panel A were incubated in kinase buffer containing γ-[32P]ATP in the absence (lanes 1, 6, and 11) or presence HFS-ETAA1
protein (lanes 2–5, 7–10, and 12). Some incubations also contained RPA (lanes 3, 5, 8, and 10–12), ssDNA (lanes 4–5, and 9–12), and
50 μM ATRi (lane 12). Reactions were subjected to SDS gel electrophoresis. The gel was stained with Coomassie blue (top panel).
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have depicted a longer exposure of the section of the gel containing 32P-labeled RPA32. For the bottom panel, we electrophoresed
aliquots of the same samples in a different gel and performed immunoblotting with anti-phospho-RPA32 antibodies.
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this critical tryptophan (W) to arginine (R) in both
human and Xenopus TopBP1 abolishes the ATR-
activating function [8]. This residue corresponds to
W107 of human ETAA1 [19,21,22]. In Xenopus
ETAA1, this position is equivalent to W63 (Figure
6(a)). We produced a W63R mutant of Xenopus
HFS-ETAA1 in baculovirus-infected insect cells
and tested this protein for its ability to promote the
phosphorylation of RPA by ATR-ATRIP (Figure 6
(b)). We observed that the HFS-ETAA1-W63R pro-
tein exhibited no activity in the kinase assay (Figure
6(c)). Thus, the phosphorylation of RPA that we
have observed in our experiments requires an intact
AAD in ETAA1.
In principle, the enhanced phosphorylation of RPA
by ATR-ATRIP in the presence of ETAA1 and
ssDNA could be due to the co-localization of ATR-
ATRIP, ETAA1, and RPA on the DNA. Alternatively,
RPA-ssDNA might act directly on ETAA1 to stimu-
late its ability to activate ATR-ATRIP, perhaps by
eliciting a conformational change in ETAA1. These
possibilities are not necessarily mutually exclusive. It
is also possible that RPA32 bound to ssDNA could
serve as a better substrate for ATR-ATRIP, but we
likewise observe enhanced phosphorylation of
ETAA1 on RPA-ssDNA. In order to explore these
possibilities, we made use of a mutant Xenopus
ATRIP called ΔN222 [50]. This mutant lacks the
N-terminal RPA-binding domain of ATRIP and
thus cannot associate effectively with ssDNA through
RPA. An analogous mutant was first described in the
case of human ATRIP [51].
Accordingly, we prepared complexes of ATR-
ATRIP containing either wild-type (WT) or ΔN222
ATRIP and compared these complexes side-by-side
for their activity in the ETAA1-dependent phosphor-
ylation of RPA bound to ssDNA (Figure 7(a and b)).
We observed that the complex containing ΔN222
ATRIP also exhibited a similar strong enhancement
as the WT complex in kinase activity in the presence
of RPA and ssDNA, even though ΔN222 ATRIP
cannot associate with RPA. These experiments indi-
cate that increased phosphorylation of RPA in the
presence of ssDNA does not simply depend on the
tethering of ATR-ATRIP and ETAA1 in close proxi-
mity on ssDNA. Overall, these experiments indicate
that association of ETAA1 with RPA-ssDNA strongly
enhances its ability to activate ATR-ATRIP, which we
have monitored through phosphorylation of RPA.
This in vitro system should be valuable for further
characterization of the ETAA1-mediated activation of
ATR-ATRIP.
Discussion
The Xenopus egg-extract system was previously
utilized for the demonstration that TopBP1 serves
as a direct activator of the ATR-ATRIP complex
[8]. In these studies, removal of TopBP1 from egg
extracts resulted in the virtual elimination of the
activation of ATR-ATRIP in response to the addi-
tion of APH. In view of the recent discovery of
ETAA1, another activator of ATR, it was impor-
tant to assess the role of this protein in the egg-
extract system. In this report, we have confirmed
that TopBP1 is the predominant, if not exclusive,
activator of ATR for phosphorylation of Chk1 in
response to stalled replication forks (as well as
double-stranded DNA breaks) in egg extracts.
We observed that TopBP1 is significantly more
abundant than ETAA1 in egg extracts. Therefore,
we examined whether the addition of extra recom-
binant ETAA1 could support phosphorylation of
Chk1 in extracts that had been depleted of their
endogenous TopBP1. As described above, in order
to carry out these experiments, we needed to sup-
plement the TopBP1-depleted extracts with
a fragment of TopBP1 that could sustain DNA
replication but not activation of ATR. Under these
conditions, we observed that extra recombinant
ETAA1 could support ATR-dependent phosphor-
ylation of Chk1 and RPA in APH-treated extracts.
Along similar lines, the concentration of
ETAA1 varies substantially in different human
cell lines [21]. For example, U2OS cells express
considerably lower levels of ETAA1 than HeLa
cells. Thus, knockdown of TopBP1 abolished
hydroxyurea-induced phosphorylation of Chk1 in
U2OS cells but not in HeLa cells [21]. Consistent
with the results presented here, overexpression of
GFP-ETAA1 restored phosphorylation of Chk1 in
hydroxyurea-treated, TopBP1-depleted U2OS
cells. Nonetheless, there appear to be significant
qualitative differences between the pathways con-
taining TopBP1 and ETAA1. For example, even
though depletion of ETAA1 did not affect phos-
phorylation of Chk1 in U2OS cells, there was
a reduction in phosphorylation of RPA [19].
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It was recently shown in human cells that ETAA1
promotes sustained activity of ATR during an unper-
turbed S-phase to suppress a mitotic transcription
factor [52]. Since there is minimal transcription and
no G2 phase in early Xenopus development, this type
of regulation would not need to be operable at this
stage [53]. We also have not been able to detect any
effect on replication during an unperturbed S-phase
in ETAA1-depleted extracts, but there is also a rapid
S-phase characteristic of early embryogenesis in egg
extracts. After submission of this manuscript, Bass
and Cortez [54] reported that removal of ETAA1
from human cells weakens the spindle checkpoint
response. This checkpoint is absent in dividing early
Xenopus embryos [55]. It will be interesting to evalu-
ate the role that ETAA1 plays at later stages of
Xenopus embryonic development.
It is important that AAD-containing proteins such
as TopBP1 and ETAA1 carry out the activation of
ATR only under the appropriate circumstances.
Accordingly, the interaction of TopBP1 with ATR-
ATRIP is regulated by a number of other proteins,
such as the 9-1-1 and MRN complexes. To explore
this issue for ETAA1, we set out to develop an in vitro
system with defined components. Since we could not
observe good phosphorylation of model substrates in
the presence of only recombinant ETAA1 and ATR-
ATRIP, we tested the addition of other components.
RPA was a clear candidate because ETAA1 exhibits
a highly specific interaction with this protein [19–22].
We could detect phosphorylation of RPA in the pre-
sence of ETAA1 and ATR-ATRIP. However, when
we performed these reactions in the additional pre-
sence of ssDNA, which would efficiently recruit RPA,
we observed a dramatic increase in the phosphoryla-
tion of the RPA32 subunit of the complex. Thus,
RPA-ssDNA acts as strong positive effector in the
ETAA1-mediated activation of ATR-ATRIP.
These observations suggest that docking of ETAA1
onto RPA-ssDNA in living cells would result in
Figure 6. ETAA1-dependent phosphorylation of RPA requires an intact AAD. (a) Alignment of AADs around the critical tryptophan
residues in ETAA1 and TopBP1 from Xenopus laevis and humans. The conserved tryptophan (W63) in Xenopus ETAA1 is denoted with
an asterisk. (b) Wild-type (WT) and mutant W63R HFS-ETAA1 proteins were purified with anti-FLAG antibodies as described in
Materials and Methods and stained with Coomassie blue. (c) Control eluates (lanes 1–5) and eluates containing ATR-ATRIP
complexes (lanes 6–12) were incubated in kinase buffer containing γ-[32P]ATP in the absence of recombinant HFS-ETAA1 (lanes 1
and 6) or the presence of either WT (lanes 2–3 and 7–9) or W63R HFS-ETAA1 protein (lanes 4–5 and10-12). Some incubations also
contained RPA (lanes 3, 5, 8–9, and 11–12) and ssDNA (lanes 3, 5, 9, and 12). Reactions were subjected to SDS gel electrophoresis.
The gel was stained with Coomassie blue (top panel). Incorporation of 32P into proteins was detected by phosphorimaging (bottom
panel). The portion of the image containing 32P-RPA32 is depicted.
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a significant increase in the kinase activity of ATR-
ATRIP. From our in vitro studies, it is not possible to
discern whether this form of ATR-ATRIP would cor-
respond to a fully activated in vivo version.
Nonetheless, it seems likely that the substantial
amount of kinase activity that we observe in the pre-
sence of only ETAA1, ATR-ATRIP, and RPA-ssDNA
would be physiologically impactful. By analogy with
TopBP1, it seems plausible, even likely, that additional
factors might contribute to the stabilization or further
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Figure 7. RPA-ssDNA can still promote activation of a mutant ATR-ATRIP complex that lacks the RPA-binding domain in ATRIP. (a)
Control eluates (lanes 1–2) and eluates containing ATR in a complex with either full-length ATRIP (lanes 3–6) or ΔN222 ATRIP (lanes
7–10) were incubated in kinase buffer containing γ-[32P]ATP in the absence (lanes 1, 3, and 7) or presence HFS-ETAA1 protein (lanes
2, 4–6, and 8–10). Some incubations also contained RPA (lanes 5–6 and 9–10) and ssDNA (lanes 6 and 10). Reactions were subjected
to SDS gel electrophoresis. The gel was stained with Coomassie blue (top panel). Incorporation of 32P into proteins was detected by
phosphorimaging (middle panel). The portion of the image containing 32P-RPA32 is depicted. For the bottom panel, we electro-
phoresed aliquots of the same samples in a different gel and performed immunoblotting with anti-phospho-RPA32 antibodies. (b)
ATR-ATRIP complexes. Full-length (lane 1) and ΔN222 versions of ATRIP-FLAG (lane 2) were added to egg extracts containing anti-
FLAG M2 antibody beads. After incubation, the beads were reisolated, washed, and eluted with 3X-FLAG peptide. The eluates were
immunoblotted with anti-ATR (top) and anti-ATRIP antibodies (bottom).
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stimulation or both of the ETAA1-activated form
ATR-ATRIP complex in living cells.
Previous studies have indicated that RPA is
a significant ultimate target of the ETAA1-
dependent pathway [19–22]. Our studies have rein-
forced this concept by showing explicitly that RPA is
a direct in vitro substrate of ETAA1-activated ATR-
ATRIP, as would be anticipated from the in vivo
studies. Within the human RPA complex, we
observed phosphorylation of RPA32, but not
RPA70 and RPA14. Using anti-phosphopeptide
antibodies, we have found that Ser-33 of RPA32 is
well phosphorylated in our biochemical reactions.
This site has been documented as a physiologically
important target of ATR [47,48].
In closing, we have utilized the Xenopus egg-
extract system to illuminate significant features of
the role and regulation of ETAA1. The use of
diverse experimental systems enhances under-
standing of key cellular regulatory molecules.
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